Zabaxa combined IV infusion contains ceftolozane sulfate-tazobactam sodium and is indicated for treating complicated intra-abdominal infections (in combination with metronidazole), complicated urinary tract infections, and hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Manufactured by MSD, it has a YJ code of 6139506D1020 and is supplied as a 1.5g bottle.
Zabaxa combined IV infusion
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).